Extract
Biotechnology Start-up Nuon Therapeutics Inc. Completes $5 Million Series A Financing and Names Management Team.
Capital Will Support Clinical Studies of Lead Compound Targeting MS, RA and Pain
SAN FRANCISCO -- Nuon Therapeutics Inc., a newly established clinical stage biotechnology company, today announced the completion of a $5 million Series A financing with GBS Venture Partners of Australia. The company also announced that R...See the full content of this document
Sponsored links
